Figure 1From: Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan Disposition of patients with pulmonary alveolar proteinosis (PAP) who were enrolled into this study. Participants were stratified according to the presence or absence of granulocyte/macrophage-colony stimulating factor (GM-CSF) autoantibody, and then according to the presence or absence of an underlying disease known to cause PAP.Back to article page